Community pharmacist perceptions of their role and the use of social media and mobile health applications as tools in public health by Crilly, Philip et al.
Accepted Manuscript
Community pharmacist perceptions of their role and the use of social media and
mobile health applications as tools in public health
Philip Crilly, Wasim Hassanali, Gary Khanna, Kiranjit Matharu, Deep Patel, Disha
Patel, Fahmida Rahman, Reem Kayyali
PII: S1551-7411(17)30689-7
DOI: 10.1016/j.sapharm.2018.02.005
Reference: RSAP 1013
To appear in: Research in Social & Administrative Pharmacy
Received Date: 20 August 2017
Revised Date: 12 February 2018
Accepted Date: 14 February 2018
Please cite this article as: Crilly P, Hassanali W, Khanna G, Matharu K, Patel D, Patel D, Rahman F,
Kayyali R, Community pharmacist perceptions of their role and the use of social media and mobile
health applications as tools in public health, Research in Social & Administrative Pharmacy (2018), doi:
10.1016/j.sapharm.2018.02.005.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
RESEARCH PAPER 
Community pharmacist perceptions of their role and the use of social media and mobile health 
applications as tools in public health  
Philip Crilly, M.Pharm., Wasim Hassanali, M.Pharm., Gary Khanna, M.Pharm., Kiranjit Matharu, 
M.Pharm., Deep Patel, M.Pharm., Disha Patel, M.Pharm., Fahmida Rahman, M.Pharm., Reem 
Kayyali, PhD. 
School of Life Sciences, Pharmacy and Chemistry, Kingston University, United Kingdom 
Mr Philip Crilly  
 
School of Life Sciences, Pharmacy 
and Chemistry, Kingston University, 
KT1 2EE 
P.Crilly@kingston.ac.uk 
0208 8417 6377 
• Conception and design of the study 
• Revised the study critically  
• Pharmacist interviews 
• Drafting of paper 
• Final approval of version to be 
published  
Mr Wasim 
Hassanali 
School of Life Sciences, Pharmacy 
and Chemistry, Kingston University, 
KT1 2EE 
wasim134@hotmail.com 
• Survey creation and collection  
• Drafting paper  
• Approval of finished work 
Mr Gary Khanna School of Life Sciences, Pharmacy 
and Chemistry, Kingston University, 
KT1 2EE 
gary_khanna@hotmail.co.uk 
• Survey creation and collection  
• Drafting paper  
• Approval of finished work 
Ms Kiranjit 
Matharu 
School of Life Sciences, Pharmacy 
and Chemistry, Kingston University, 
KT1 2EE 
kkm1992@hotmail.co.uk 
• Survey creation and collection  
• Drafting of paper 
• Approval of finished work 
Mr Deep Patel School of Life Sciences, Pharmacy 
and Chemistry, Kingston University, 
KT1 2EE 
deep1402@hotmail.co.uk 
• Survey creation and collection  
• Drafting paper  
• Approval of finished work 
Ms Disha Patel School of Life Sciences, Pharmacy 
and Chemistry, Kingston University, 
KT1 2EE 
Disha.patel1993@hotmail.com  
• Survey creation and collection  
• Drafting paper  
• Approval of finished work 
Ms Fahmida 
Rahman 
School of Life Sciences, Pharmacy 
and Chemistry, Kingston University, 
KT1 2EE 
fahmida.r@hotmail.co.uk 
• Survey creation and collection  
• Drafting paper  
• Approval of finished work 
Dr Reem Kayyali 
(Corresponding 
author) 
School of Life Sciences, Pharmacy 
and Chemistry, Kingston University, 
KT1 2EE 
R.Kayyali@kingston.ac.uk 
0208 417 2561 
• Conception and design of the study 
• Revised the study critically  
• Final approval of version to be 
published  
 
 
Acknowledgements 
This research is  
Conflicts of interest 
None 
Funding 
This work was supported by the National Pharmacy Association Health Education Foundation (NPA HEF).  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
1 
 
ABSTRACT  1 
Background. A number of barriers prevent community pharmacists (CPs) from impacting 2 
public health (PH) outcomes. Social media (SM) and mobile health apps (MH apps) may 3 
offer ways to help the public make positive health decisions.  4 
Objectives. To evaluate CP perceptions of their role in PH and the use of SM and MH apps 5 
in this regard.  6 
Methods. This was a mixed method study using a cross-sectional survey and follow-up 7 
interviews. The survey covered: CPs role in PH; CP use of SM; CP use of MH apps; non-8 
identifiable demographic information. Following ethical approval and piloting, responses 9 
were collected on paper and online. The study population was CPs in Greater London, UK 10 
(n=2931). A minimum sample size of 340 was calculated (95% confidence interval/5% 11 
margin of error). To achieve this, 596 surveys were distributed. Responses (n=257) were 12 
analysed using descriptive statistics. Twenty-five respondents were willing to take part in 13 
follow-up one-to-one interviews. Twenty interviews were completed as data saturation was 14 
achieved after the 14th. Interviews were transcribed and analysed using framework 15 
methodology as described by Ritchie and Spencer in 1994.   16 
Results. Survey response rate was 43%. Respondents represented English CPs in terms of 17 
age but males and non-whites were over-represented. The majority of CPs accessed SM and 18 
MH apps for personal use but did not recommend these in a professional capacity due to lack 19 
of awareness and confidentiality/liability concerns. Most would promote an SM health page 20 
(78.6%) or MH app (83.7%) if maintained by healthcare professionals (HCPs). Under 35s 21 
were more positive about these tools in PH. Two interview themes emerged: The role of CPs 22 
in PH; Concerns and opportunities for the use of technology in PH.  23 
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Conclusions. Most CPs, particularly those under 30, were positive about the use of SM and 24 
MH apps in PH. Training on the use of such tools among the pharmacy team, and an 25 
awareness of the availability of evidence-based apps will ensure their wider adoption.  26 
Key words. Community pharmacy; public health; digital health; social media; mobile health 27 
applications.  28 
 29 
INTRODUCTION 30 
Ten years since the introduction of the community pharmacy contractual framework (CPCF) 31 
in England, the delivery of public health services and campaigns by community pharmacists 32 
(CPs) are now well established.1,2 Many CPs play a public health role by running clinics to 33 
support people to lose weight, to stop smoking, or to reduce their cardiovascular disease risk, 34 
as well as delivering six public health campaigns each year, as directed by NHS England.3,4 35 
In addition, some community pharmacies are now classified as Healthy Living Pharmacies 36 
(HLP), utilising the skills of pharmacy support staff to improve public health.5 The British 37 
government has recently announced funding cuts in England that will have a direct impact on 38 
the delivery of pharmacy public health services,6 with many having to be decommissioned, 39 
particularly if they are unable to demonstrate their impact on patient health outcomes.1 40 
 41 
Advances in digital technology have given healthcare professionals (HCPs), including CPs, 42 
opportunities to improve public health.7–19 In fact, Shaw et al.11 have pointed out that most 43 
“health and wellbeing” happens away from a HCP. The majority of patients see a HCP only 44 
once or twice a year and outside of these meetings they need to make their own health-related 45 
decisions. In the same report the term E-health was refined into three domains (1) the use of 46 
digital devices to monitor or track health; (2) the use of digital tools for communication 47 
between HCPs and patients; and (3) the use of digital tools for health data and the use of that 48 
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data to influence health advice.11 E-health interventions that combine all three domains are 49 
seen as the gold standard.11  50 
 51 
Aungst et al.20 noted that the in-built features of a smartphone e.g. camera and microphone, 52 
make them useful devices for communication between HCPs and patients. Their report also 53 
noted that high smartphone ownership among all demographics reduces inequalities related to 54 
access to the internet and mobile health apps applications (MH apps). MH apps in particular 55 
have been investigated for their role in helping the public to adopt positive health behaviours 56 
and to manage health conditions and treatments,21–23 and a number have been shown to 57 
include behaviour change theory.24 Therefore, MH apps may present an effective method of 58 
continuing to motivate patients outside of the pharmacy with an added benefit that they do 59 
not require an internet connection, although they do need to be regularly updated to ensure 60 
that they function to a high standard.20 61 
 62 
Recent data by the Office of National Statistics (ONS)25 shows that the majority of the United 63 
Kingdom (UK) population are online with 63% of these also having a social media (SM) 64 
profile as of 2016; up from 45% in 2011; with Facebook being the most popular platform.26 65 
Universities teaching undergraduate pharmacists are also starting to incorporate SM into their 66 
training.27 The use of SM has been proposed to potentially challenge traditional health 67 
promotion models by Chou et al.8 However, the study highlighted that it is important to 68 
identify which SM platforms patients use before embarking on any interventions that use this 69 
technology.8 In a study by Benetoli et al.13 CPs noted that Facebook was the most effective 70 
SM platform for sharing public health messages due to a number of beneficial design 71 
features, such as the ability to share written, photographic and video content as well as the 72 
opportunity to comment on content shared by others and to network.  In fact, Cain et al.14 73 
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pointed out that the “community” feel of SM complements the same feelings that people 74 
associate with using a community pharmacy.  75 
 76 
Examples of how CPs have used SM for public health include the use of video-sharing 77 
platform, YouTube, to show patients how to correctly use their inhalers,13 and using 78 
Facebook and Twitter to share information about public health and environmental crises, 79 
such as during the Ebola outbreak,13 and during hurricanes and floods.14 Video was 80 
particularly highlighted as an effective way to share health information with those with low 81 
literacy levels.13 While digital tools are showing promise in terms of their role as tools in 82 
public health, HCPs are reminded of the need to adopt “positive professional behaviours” 83 
when online.28–31  84 
 85 
While a number of studies have addressed the use of SM and MH apps in public health,8,13–86 
19,21–23,30,31
 this is the first large scale study of UK CP attitudes and perceptions of these tools 87 
in this regard.  88 
 89 
Aim 90 
This study explored UK CP perceptions of their role in public health and the barriers that are 91 
preventing them from fulfilling this role, if any. It also evaluated CP perceptions of the use of 92 
SM and MH apps in pharmacy public health services, focusing on whether demographic 93 
factors affect acceptability of SM and MH apps, and how CPs might incorporate such tools 94 
into their future service delivery.  95 
 96 
 97 
 98 
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METHOD 99 
This was a mixed-methods study investigating CP perceptions of their role in public health 100 
and the use of SM and MH apps in this regard. A triangulation method was used with the 101 
survey acting as the main tool and the interview used to validate the findings from the 102 
survey.32 103 
 104 
Phase 1 – Survey tool  105 
The perceptions of the general public and HCPs on the use of digital tools in public health 106 
had been previously investigated, however, the search highlighted a gap in the knowledge 107 
about UK CP perspectives of the role of such tools in public health.7,9,13–24,29-31,33 A survey 108 
tool was, therefore, created to address this gap and consisted of 47 questions divided into 4 109 
sections: the role of CPs in public health; the use of SM by CPs; the use of MH apps by CPs; 110 
and demographic data. A 5-point Likert scale (agree, somewhat agree, neither agree nor 111 
disagree, somewhat disagree, disagree) was adapted from a study by Shcherbakova and 112 
Shepherd17 who investigated American (Texas State) CP use of digital communication tools. 113 
The majority of the remaining questions were closed, with pre-formulated answer choices. 114 
An “other” option was provided to allow CPs to enter free text answers if their preferred 115 
answer was not listed. An additional removable section explained that the researcher was 116 
conducting future interviews. CPs who were interested in taking part in the interview stage 117 
were asked to provide their email address and/or telephone number in this section and this 118 
was then separated from the main survey by the researcher collecting responses before the 119 
survey responses were analysed by another researcher. The survey was internally reviewed 120 
for content validity by an expert in the field and assessed for face validity by 2 colleagues. It 121 
was piloted by 30 CPs (who were then excluded from the data analysis), and, as a result, 122 
minor changes were made to the wording of seven questions. The average time taken to 123 
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complete the survey was 20 minutes. The final version of the survey is available in Appendix 124 
1. 125 
 126 
Study sample 127 
The study population was all CPs working in community pharmacies (n=1879) in Greater 128 
London.34 The community pharmacy workforce in London report identified that the average 129 
number of CPs working in a Greater London community pharmacy was 1.56.34 The total 130 
population size for this study, therefore, was estimated to be 2931 CPs. A recommended 131 
minimum sample size of 340 was calculated using Raosoft sample size calculator providing a 132 
confidence level of 95% with a margin of error of 5%.35 A report by Sitzia and Wood36 noted 133 
that mean response rates for face-to-face surveys was 76.6%, therefore, in an attempt to 134 
maximise the number of responses, 596 surveys were distributed. Community pharmacies 135 
within the research area were assigned a number; this was then randomised using an online 136 
randomisation tool. The data collection aspect of this study was carried out by multiple 137 
research students (N=6) who were each assigned a different area in Greater London to collect 138 
survey responses. The majority of surveys were hand delivered with researchers encouraging 139 
face-to-face completion. For those respondents who could not complete the survey 140 
immediately, the researcher either agreed a future date to collect the survey or provided them 141 
with a stamped address envelope to post the survey back. All CPs were given a participant 142 
information sheet (PIS) and asked to complete and return their survey within two weeks. The 143 
researcher telephoned every CP after this deadline to check if they had returned their survey 144 
and to encourage them to do so if they had not. For those who had misplaced their survey a 145 
new one was distributed by post with a stamped addressed envelope included to encourage its 146 
return. An online survey was also offered to aid completion. Completion of the survey was 147 
accepted as informed consent.  148 
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Statistical analyses 149 
Responses were coded and entered into SPSS for Windows, version 23 (International 150 
Business Machines (IBM), New York). As the data was non-normally distributed and ordinal 151 
in nature, chi-square tests were used to identify any associations between responses. Sub-152 
analyses were performed by respondents’ gender, age, ethnicity, type of pharmacy worked in 153 
and number of years qualified. An a priori level of less than 0.05 (p<0.05) was set as 154 
significant.  155 
 156 
Phase 2 – Semi-structured interviews  157 
Six months after completion of the survey, all respondents who indicated that they were 158 
willing to participate in the second phase of the study were invited for a semi-structured 159 
interview. Of the 257 CPs who completed the survey, 50 included their contact details for 160 
interview. All 50 CPs were sent a PIS, explaining what the interview would entail. Two 161 
weeks later they were contacted to confirm if they had read the PIS and to ask if they were 162 
still willing to participate in the study. Twenty CPs declined citing “lack of time” as their 163 
main reason. Those who confirmed their interest were sent a consent form to sign and return 164 
in a stamped-addressed envelope and told that they would be contacted in due course. 165 
Twenty-five CPs returned their consent forms and a time schedule for interviews was 166 
prepared. Data saturation was achieved following 14 interviews, however, a further six 167 
interviews were conducted.37 Conducting interviews with the remaining 5 CPs was deemed 168 
unnecessary and they were thanked for their willingness to participate. The interview 169 
schedule was designed to allow respondents to expand on their survey responses and 170 
consisted of 19 questions (Appendix 2). This was piloted by 5 CPs (who were then excluded 171 
from the data analysis) and no changes were recommended. Interviews were conducted 172 
between November and December 2016 by one researcher.  173 
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Interviews were conducted either at the place of work of the CP, with only the interviewer 174 
and interviewee present, or over the telephone. Each interview took approximately 15 175 
minutes to complete. These were digitally audio-recorded with the permission of the 176 
interviewee. Hand-written notes were also taken during the interview. Verbatim written 177 
transcripts of each recording were prepared and participants were sent a password-protected 178 
digital copy of their own transcript via email and asked to comment on its accuracy. Only one 179 
respondent replied to this request and added no new information to the transcript.  180 
 181 
Thematic analysis, as described by Braun and Clarke,38 was used in this study. Initial codes 182 
were identified by firstly listening to the recorded interviews and reading and re-reading the 183 
written transcripts and hand-written notes. Once all transcripts had been read and re-read and 184 
all emerging codes had been identified the analytical framework was developed further.39 The 185 
coded transcripts were checked by a second researcher. A discussion followed between the 186 
two researchers and codes were then arranged into broad categories, namely CPs role in 187 
public health; Barriers to CP public health role; Opportunities for using technology in public 188 
health; and barriers for using technology in public health. These categories were then 189 
examined and grouped into two meaningful themes. Coding and thematic analysis, were 190 
managed in NVivo qualitative data analysis Software, version 11 (QSR International Pty 191 
Ltd). Results are presented as themes with quotes from interviews used to support these. 192 
Following a similar approach to Morton et al.4 participants were provided with pseudonyms 193 
indicating: the type of community pharmacy worked in; the participant number; and number 194 
of years qualified. For example, participant “IndepCP1 (8 years)” would refer to a community 195 
pharmacist working in an independent/small chain pharmacy, qualified for 8 years; while 196 
participant “MultiCP1 (5 years)” would refer to a community pharmacist working in a large 197 
multiple chain pharmacy and qualified for 5 years.  198 
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Ethical approval 199 
The delegated ethical approval team operating within the academic institute of the authors 200 
granted ethical approval for the survey tool in March 2016 (1213/045) and the interview 201 
schedule on 18th November 2016 (1617/005). 202 
 203 
RESULTS 204 
In order to reach the recommended minimum sample size (N=340), 596 surveys were 205 
distributed. Of these, a total of 257 were completed, giving a response rate of 43%. Those 206 
who completed the survey were mostly under 35, which matches the English CP 207 
demographic statistics (see table 1). Respondents were not representative of English CP 208 
statistics in relation to gender and ethnicity, with male respondents (58%) and non-white 209 
respondents (80.8%) being over-represented.  210 
 211 
Pharmacist delivery of public health services and campaigns 212 
Regardless of the demographics, over half the respondents (n=140, 54.9%) had delivered at 213 
least one public health campaign during the previous year. The most common communication 214 
methods used to follow-up with those patients who had interacted with the health campaigns 215 
included: face-to-face consultation (63.4%); and telephone call (23.6%). Email 216 
correspondence and an interaction on social media accounted for just 4.3% and 1.4% 217 
respectively.  218 
 219 
Of those who did not deliver any public health campaigns during the previous year (n=115, 220 
45.1%), lack of time (82.6%) was given as the number one barrier that had prevented them 221 
from doing so.  222 
 223 
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Use of social media 224 
Almost three-quarters (n=187, 72.8%) of respondents have an account on SM with 77.5% of 225 
these logging on at least once daily. Facebook was the most popular platform followed by 226 
LinkedIn, YouTube, Instagram and Twitter. Those under 35 were more likely to have a SM 227 
account (p=0.021) as were those working for a pharmacy multiple (p=0.011). There was no 228 
association between the type of pharmacy worked in and age.  229 
 230 
Over half of those who use SM (n=107, 57.2%) do so in a professional capacity with 34% of 231 
these choosing to have separate personal and professional accounts. CPs used SM to connect 232 
with other CPs (82.2%); to stay up-to-date with health literature (39.3%); and to connect with 233 
other healthcare professionals (37.4%). A minority (15.0%) did so to connect with patients.  234 
 235 
Over a third of those who use SM (n=65, 34.9%) were allowed to do so at their workplace. 236 
CPs working at independent or small chain pharmacies were more likely to be allowed to use 237 
SM at work (p=0.001). Despite being allowed to, only eight respondents used SM at work to 238 
promote public health topics. Reasons for not recommending SM health pages included: not 239 
aware of any health SM pages (56.4%) and never thought to suggest (42.4%). CPs did note, 240 
however, that patients often asked them to discuss information they had found on SM (n = 241 
90, 35.0%). Frequently, the information referred to by patients was inaccurate, with CPs 242 
believing it to be from advertisements or unregulated SM pages.  243 
 244 
Most CPs were positive about the potential use of SM as a tool in health promotion, however, 245 
a large proportion were reluctant to use it in their own communication with patients. In 246 
addition, many were unsure about integrating SM into pharmacy services with nearly three-247 
quarters indicating that better guidelines were needed on how CPs could use SM (see table 248 
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2a). It was noted that the under 35s were consistently more positive about the use of SM in 249 
health promotion than the over 35s (see table 3). There were no statistical differences in 250 
opinions based on gender or ethnicity.  251 
 252 
Asked if they would promote an SM health page created and maintained by healthcare 253 
professionals over three-quarters (n=202, 78.6%) stated that they would. The under 35s were 254 
more likely to recommend such a page (p<0.001). Almost two-thirds (n=128, 63.4%) of those 255 
who would recommend a SM health page would also be willing to prepare health-related 256 
posts for the page with the under 35s being more likely to be prepared to do so (p<0.001). 257 
Many (66%) would, however, expect some form of remuneration ranging from between £1 258 
and £20 per health post published. Topics to promote included: smoking cessation (95.5%), 259 
diabetes (83.2%), physical activity (78.7%), sexual health (77.2%), weight management 260 
(77.2%) and alcohol awareness (76.7%).  261 
 262 
Liability and accountability (53.8%); concerns about patient confidentiality (51.9%); and lack 263 
of understanding of how to use SM (38.5%) were the main reasons given by those who would 264 
not recommend a SM page created and maintained by healthcare professionals (n=55).  265 
 266 
Use of mobile health apps  267 
Almost two-thirds (n=162, 63%) of respondents have access to a smart phone or tablet device 268 
in their pharmacy. Despite this only 13.2% recommend any MH apps to patients for health 269 
advice. There were no significant differences based on gender, age, ethnicity or the type of 270 
pharmacy worked in. Reasons for not recommending any MH apps included: not aware of 271 
any MH apps (61.1%); never thought to suggest it (46.3%); and don’t trust MH apps (17.9%).  272 
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As with SM, most CPs were positive about the potential use of MH apps as tools in health 273 
promotion but again many were reluctant to use them in their own practice currently. A large 274 
proportion felt that better guidelines were needed to support CPs to use MH apps. (see table 275 
2b) with the under 35s again being more likely to support their use (see table 3).  276 
 277 
Respondents were positive about recommending a MH app created and maintained by 278 
healthcare professionals (83.7%) with the under 35s again more likely to recommend this 279 
(p<0.001). Recommended topics to include in such an app included smoking cessation 280 
(94.9%), physical activity (85%), diabetes (85%), weight management (79.9%) and sexual 281 
health (79.4%). Those who would not recommend such an app to patients stated reasons 282 
including a concern about patient confidentiality (46.3%), liability and accountability 283 
(39.0%). 284 
 285 
Interviews 286 
In this study the final sample size was 20 participants. Demographics of those interviewed 287 
can be found in table 4. Two key themes emerged from the analysis: 288 
• The role of CPs in public health 289 
• Concerns and opportunities for the use of technology in public health 290 
 291 
The role of CPs in public health 292 
All interviewees stated that they thought the profession had an important role to play in 293 
public health citing reasons including: the pharmacist is accessible without an appointment 294 
and pharmacies are in convenient locations.  295 
 296 
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“I do positively believe that we have a very strong role in public health – in everything – 297 
good lifestyle advice, essential in diabetics – overweight, dietary advice, walking – correct 298 
exercise for age, stop smoking” IndepCP6 (19 years) 299 
 300 
Common barriers identified by interviewees as being limiting factors in their public health 301 
role included lack of remuneration, lack of time, poor commissioning decisions and lack of 302 
national service commissioning. But one CP in particular felt that the pharmacy profession 303 
did not know how to maximise its opportunities.  304 
 305 
“I don’t think we are that good at proactively offering public health advice and services to 306 
people that are just coming in to the pharmacy to collect their prescriptions or buy things 307 
over-the-counter. We are not making the most of the opportunities” IndepCP4 (8 years) 308 
 309 
Some CPs (n=3/20) felt frustrated by commissioning decisions made within their locality and 310 
believed that they could do much more in the domain of public health if they were supported 311 
by commissioners.  312 
 313 
“We’re a 100-hour pharmacy so we are open a lot… when we explain that to the local 314 
authority they say, ‘The other pharmacy is already offering this service.’ Yes, but they are 315 
only open 45-hours per week. We’re open over two times more… we can’t provide the service 316 
because they won’t provide us with the funding.” IndepCP8 (12 years) 317 
 318 
“For the majority of public health services there’s no consistency – one borough does 319 
smoking and not the other. One borough gives vitamins to children and not the other – it’s a 320 
mess.” IndepCP10 (30 years) 321 
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This highlights that CPs do not feel listened to by commissioners and that they are being 322 
overlooked for new public health service opportunities. The commissioning of the national 323 
flu service, however, was highlighted by one interviewee as the exemplar model for 324 
pharmacy service commissioning.  325 
 326 
“If you look at the flu jab, over the years we are doing more because everyone is doing it. 327 
The public is aware that if you want a flu jab you can go to the GP or pharmacy – it’s well 328 
promoted.” IndepCP10 (30 years) 329 
 330 
Some CPs (n=7/20) prioritise services based on the remuneration offered. The changing 331 
nature of their job role also appears to be a challenge, particularly in relation to finding the 332 
time to offer public health services.  333 
 334 
“The incentive to do more is always going to be driven by money. I know lots of pharmacists 335 
who don’t actively take part in certain public health services because they feel it’s not 336 
remunerated properly.” MultiCP8 (18 years) 337 
 338 
“… the problem with services is that you have so much else to do. And I do over 12,000 items 339 
so you know it’s really busy so to go into the consultation room and then come out, you just 340 
get daggers from everybody. MultiCP4 (4 years) 341 
 342 
Interestingly, the role of pharmacy support staff was highlighted by a number of interviewees 343 
(n=5/20) as a way to support patients. 344 
 345 
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“So I think the pharmacist is important but the role of support staff is even more important as 346 
they may be the first person that a patient comes across” MutliCP6 (10 years) 347 
 348 
Concerns and opportunities for the use of technology in public health 349 
The majority (n=16/20) of CPs were positive about the use of technology, in particular SM 350 
and MH apps, as tools in public health service delivery as a means to enable them to reach 351 
those people who do not visit a pharmacy.  352 
 353 
“You may appeal to more people on social media who don’t necessarily come into your 354 
pharmacy.” IndepCP4 (8 years) 355 
 356 
CPs identified a number of barriers that they felt would prevent them from using technology 357 
in public health. The main barriers were related to liability and privacy concerns. However, 358 
while some CPs (n=5/20) had concerns about the privacy of patients on digital mediums, 359 
others (n=8/20) felt that people today are much more open to sharing information about 360 
themselves online. They felt that pharmacy needed to embrace the changing nature of 361 
communication or risk being left behind.  362 
 363 
“If someone is talking about lower urinary tract infection – it’s a personal matter… if you 364 
start talking about that in a public forum, it’s very sensitive, embarrassing for an adult.” 365 
IndepCP6 (19 years) 366 
 367 
“Modern 21st century people are… much more open to things – it’s about sharing, it’s about 368 
understanding their illness, and it’s about using technology… It’s a good thing –it’s the way 369 
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forward, there’s no choice, nothing is going to stop it, it’s going to happen anyway so we 370 
might as well embrace it” IndepCP2 (13 years) 371 
 372 
Another concern for CPs (n=6/20) using SM to communicate with the public was the risk of 373 
intrusion into their private life. Some (n=3/20) also felt that it would have an impact on the 374 
pharmacist-patient relationship.  375 
 376 
“The 24-7 nature of social media. Once you’re finished a long day you don’t want it 377 
infiltrating your home so it can tend to be invasive.” MultiCP8 (18 years) 378 
 379 
“I wouldn’t want to socialise with patients on social media, I would like to keep a 380 
professional relationship”. IndepCP7 (27 years) 381 
 382 
Others (n=2/20) worried that face-to-face consultations would decline, possibly revealing that 383 
the public cannot make decisions about their own health without HCP support.  384 
 385 
“… if we only go to social media then we are really going to lose that face-to-face contact.” 386 
MultiCP2 (6 years) 387 
 388 
CPs (n=7/20) were concerned about the risks of patients misinterpreting information posted 389 
on SM as they may be held to account if something went wrong.  390 
 391 
“… it’s quite difficult to control and you’re providing information that could be 392 
misunderstood. With some forms of social media you have limited characters e.g. Twitter, 393 
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you can’t really say everything you need to tell them in that space – I’d be quite wary of the 394 
liability involved and you haven’t got insurance for your social media profile.”  395 
MultiCP8 (18 years) 396 
 397 
However, a number of CPs (n=3/20) had already cautiously started using technology in their 398 
public health communications with patients while taking a number of steps to reduce any risk 399 
of liability associated with their promotion of health information on digital tools.  400 
 401 
“We have a pharmacy Facebook page… rather than re-writing our own articles we rather 402 
just share articles from NHS choices directly onto social media, because someone could 403 
potentially claim that we are giving wrong information – so if we take it from CKS or NHS 404 
Choices – we are in safe hands – we share information already created by the NHS.” 405 
IndepCP8 (12 years) 406 
 407 
Lack of skills in the use of technology was not necessarily seen as a barrier for some 408 
pharmacists as they felt that their support staff would have an important role in the use of 409 
these new tools. Given the role of pharmacy support staff as health champions in Healthy 410 
Living Pharmacies (HLP), there may be scope to expand this role to include the championing 411 
of digital interventions. 412 
 413 
“… the pharmacist can prepare a message and staff could share it on social media – they’re 414 
quicker and better at the technology.” IndepCP9 (24 years) 415 
 416 
On the other hand, a number of CPs (n=3/20) highlighted that, with the right training, they 417 
would be happy to utilise technology in their practice. 418 
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“Someone needs to hold our hand and guide us through the maze – basic training - 419 
youngsters have grown up with these things – they grow up with it from day one – using a 420 
computer is no big deal to them – pharmacists in their 50’s haven't” IndepCP9 (24 years) 421 
 422 
DISCUSSION 423 
This study has identified that Greater London CPs feel that they have an important role to 424 
play in public health but that barriers such as lack of time, lack of remuneration and 425 
disjointed commissioning decisions are preventing them from doing more. The barriers 426 
identified are the same as those noted in previous research,2 however, what this study 427 
highlights is that despite an awareness of what the common barriers have been in the past, 428 
nothing has changed. Cain et al.14 noted that digital mediums could become the preferred 429 
sources of information for patients, or they could at least become an alternative to face-to-430 
face contact when this is not possible.8 These mediums may, therefore, bridge the gap and 431 
offer CPs a new approach for communicating public health messages, with Shaw et al.11 432 
noting that SM offers HCPs an opportunity to provide “just-in-time” advice to patients. 433 
 434 
CPs felt that tools, such as SM health pages and MH apps, could be used more often in the 435 
delivery of public health services but that these would need to be created and maintained by 436 
healthcare professionals. This mirrors findings by Ghafoor et al.23 who noted that the public 437 
were more likely to use a digital health tool if it was endorsed by a trusted source. 438 
Interestingly, in this study more CPs were prepared to recommend MH apps than SM health 439 
pages. Barriers reported about the use of SM included issues associated with confidentiality 440 
and patient privacy as well as the impact on the CP-patient relationship. CPs were also 441 
concerned that using SM to communicate with patients could potentially intrude into their 442 
personal life. Denecke et al.31 studied the ethical issues associated with using SM in 443 
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healthcare and noted that HCPs were often concerned about patient privacy and 444 
confidentiality on SM and that these issues would need to be addressed if SM were to be used 445 
more often in healthcare. Benetoli et al.28 pointed out that a CPs online behaviour could affect 446 
the public’s perceptions of them in their professional role. CPs, therefore, need to be 447 
conscious about their professional values online, just as they would in real life. For this 448 
reason some CPs in this study chose to have separate SM accounts, with one for their 449 
professional life and the other for personal use. Similar findings were also noted by Cain et 450 
al.14  451 
 452 
Another key finding of this study is that age is a factor in CP perceptions about the use of SM 453 
and MH apps in pharmacy public health services. CPs under 30 are more open to using these 454 
tools. Similar findings have been previously reported by Shcherbakova and Shepherd17 who 455 
noted that CPs involved in patient online communications in their study were more likely to 456 
be younger, recently qualified, and living in metropolitan areas. A previous study13 noted that 457 
some CPs see the pharmacy profession as being risk averse and reluctant to change. Older 458 
adults have been noted to be more risk averse than younger adults,40 which may explain why 459 
older CPs are more reluctant to recommend SM and MH apps. In addition, Cain et al.14 460 
identified that the reasons that HCPs don’t use SM to interact with patients is to do with their 461 
own familiarity with the software. This theme is similar to that highlighted in the interviews 462 
in this study.  Those under 30 are more likely to have grown up with SM and MH apps and so 463 
are referred to as “digital natives” while those over 30 have been described as “digital 464 
immigrants”.41 Therefore, familiarity with and perceptions about the ease of use of these tools 465 
may make the under 30s more open to using them in a professional capacity. Many will also 466 
have used these new technologies in their undergraduate pharmacy training.27 This is linked 467 
to the Technology Acceptance Model (TAM), which highlights that those who perceive new 468 
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technology to be useful and easy to use are more likely to incorporate it into their 469 
professional practice.42 This indicates that improving the digital literacy of CPs, and 470 
pharmacy team members in general, is important, with another study13 pointing out that 471 
pharmacy teams may need to learn a whole new “skill set”. This study also noted that the use 472 
of SM while at work is dependent on the type of community pharmacy worked in. Those 473 
working in independent or small chain pharmacies were more likely to be allowed to use SM 474 
at work compared to those working for large chain pharmacies. 475 
 476 
Despite the majority of CPs using SM and MH apps for personal reasons many stated that 477 
they had simply not thought to recommend these to patients, similar to a study from 2010.30 478 
Some pointed out that they had consciously decided not to recommend these, due to concerns 479 
about recommending tools that they didn’t know much about themselves. Lack of awareness 480 
of the digital tools available was also highlighted by Kayyali et al.22 A concerning finding in 481 
this study, however, is that CPs have been approached by the public to discuss information 482 
that they have accessed on digital mediums.  CPs often found the information to be inaccurate 483 
with the sources cited being advertisements and unregulated SM health pages. These findings 484 
were expanded upon in the interviews. This all highlights that the public are already using 485 
these digital mediums to search for health information and that CPs cannot ignore this. CPs 486 
must strive to incorporate these mediums into their communication with patients to maximise 487 
their impact on public health.  488 
 489 
In terms of the facilitators that could help CPs in their public health role, pharmacists noted 490 
that support staff could be utilised more. This perception is mirrored by the Healthy Living 491 
Pharmacy model which recognises the important role that healthcare assistants can play in 492 
supporting patients to make positive lifestyle changes.5 Donovan and Paudyal5 suggest that 493 
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engaging support staff and tailoring training for particular public health topics is the best way 494 
to drive the health champion initiative. The concept of the health champion could be 495 
expanded further to include a role as a digital champion. As more members of the general 496 
public utilise SM and MH apps it is important that the pharmacy profession embraces this 497 
change.  498 
 499 
CPs in this study also highlighted that they were concerned that face-to-face contact with 500 
patients would diminish if these communication tools were used more often. These fears were 501 
echoed by CPs and other HCPs in a study by Kayyali et al.19 Other participants, however, did 502 
feel that digital tools would be of particular benefit to CPs as a way to connect with people 503 
who do not normally use pharmacies. Similar to telehealth, the use of SM and MH apps will 504 
not substitute face-to-face contact but will provide an opportunity for CPs to enhance their 505 
role in public health.43  506 
 507 
The study had a number of limitations. Firstly, the sample demographic was not fully 508 
representative of CPs in Greater London and England in terms of gender and ethnicity. While 509 
the proportion of under 35s surveyed was equivalent to the local and national statistics, they 510 
were consistently more positive in their perceptions of SM in healthcare than the over 35s. 511 
This may have skewed the results more favourably for the use of SM in pharmacy public 512 
health. Secondly, despite adopting a number of different survey collection strategies the 513 
sample size was below that recommended by the sample size calculator to provide a 95% 514 
confidence level with 5% margin of error.  Thirdly, those who accepted our invitation to take 515 
part in the interview may have been more biased towards the use of SM and MH apps in 516 
healthcare, however, saturation of themes was achieved. Fourthly, the interchangeable use of 517 
the terms customer and patient in the survey tool may have affected CP responses. Finally, 518 
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the demographic section of the survey did not ask about participant job role e.g. locum 519 
pharmacist, pharmacist manager. As a result, some of the responses from transient CPs may 520 
have skewed the data giving the indication that many community pharmacies do not deliver 521 
the required six public health campaigns each year.  522 
 523 
CONCLUSION 524 
Restrictions in time and lack of remuneration are barriers preventing CPs from being more 525 
active in public health. SM health pages and MH apps offer innovative ways to deliver public 526 
health messages. CPs do have concerns about the use of these tools in public health, 527 
specifically relating to privacy and their own understanding of these mediums, however, they 528 
are willing to recommend these to their patients if they are evidence-based and are created 529 
and maintained by HCPs. Pharmacists in this study indicated that better guidelines and 530 
training need to be provided. These should address topics such as: how to use different SM 531 
platforms; how to post information on SM; and how to identify suitable SM resources and 532 
MH apps to recommend to patients. This will allow the whole pharmacy team to interact with 533 
the public on mediums that they are already using. With a rising public health burden and the 534 
already announced NHS funding cuts, the use of SM and MH apps offer CPs an opportunity 535 
to enhance their reach in PH and to achieve better PH outcomes.  536 
 537 
Conflicts of interest: none 538 
Acknowledgements  539 
The authors wish to thanks the pharmacists who took part in this study.  540 
Funding 541 
This work was supported by the National Pharmacy Association Health Education 542 
Foundation (NPA HEF).  543 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
23 
 
REFERENCES 544 
1.  Murray R. Independent Review of Community Pharmacy Clinical Services. NHS 545 
England Independent Review. https://www.england.nhs.uk/commissioning/primary-546 
care-comm/pharmacy/ind-review-cpcs/ ; 2016 Accessed 06.01.2017. 547 
2.  Eades CE, Ferguson JS, O’Carroll RE. Public health in community pharmacy: A 548 
systematic review of pharmacist and consumer views. BMC Public Health. 549 
2011;11:582. doi:10.1186/1471-2458-11-582. 550 
3.  Local Government Association. The community pharmacy offer for improving the 551 
public’s health. https://www.local.gov.uk/sites/default/files/documents/community-552 
pharmacy-offer--9b3.pdf ; 2016 Accessed 13.07.2017. 553 
4.  Morton K, Pattison H, Langley C, Powell R. A qualitative study of English community 554 
pharmacists’ experiences of providing lifestyle advice to patients with cardiovascular 555 
disease. Res Social Adm Pharm. 2015;11:e17-29. doi:10.1016/j.sapharm.2014.04.006. 556 
5.  Donovan GR, Paudyal V. England’s Healthy Living Pharmacy (HLP) initiative: 557 
Facilitating the engagement of pharmacy support staff in public health. Res Soc Adm 558 
Pharm. 2015;44. doi:10.1016/j.sapharm.2015.05.010. 559 
6.  Robinson S. How cuts to public health funding could affect pharmacy. Pharm J. 560 
2015;295:372-374. doi:10.1211/PJ.2015.20200151. 561 
7.  Yardley L, Ware LJ, Smith ER, et al. Randomised controlled feasibility trial of a web-562 
based weight management intervention with nurse support for obese patients in 563 
primary care. Int J Behav Nutr Phys Act. 2014;11:67. doi:10.1186/1479-5868-11-67. 564 
8.  Chou WS, Prestin A, Lyons C, Wen K. Web 2.0 for health promotion: reviewing the 565 
current evidence. Am J Public Health. 2013;103:e9-18. 566 
doi:10.2105/AJPH.2012.301071. 567 
9.  Benetoli A, Chen TF, Aslani P. The use of social media in pharmacy practice and 568 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
24 
 
education. Res Soc Adm Pharm. 2015;11:1-46. doi:10.1016/j.sapharm.2014.04.002. 569 
10.  Aungst TD. Medical Applications for Pharmacists Using Mobile Devices. Ann 570 
Pharmacother. 2013;47:1088-1095. doi:10.1345/aph.1S035. 571 
11.  Shaw T, McGregor D, Brunner M, et al. What is eHealth? Development of a 572 
Conceptual Model for eHealth: Qualitative Study with Key Informants. J Med Internet 573 
Res. 2017;19:e324. doi:10.2196/jmir.8106. 574 
12.  Free C, Phillips G, Galli L, et al. The Effectiveness of Mobile-Health Technology-575 
Based Health Behaviour Change or Disease Management Interventions for Health 576 
Care Consumers: A Systematic Review. Cornford T, ed. PLoS Med. 577 
2013;10:e1001362. doi:10.1371/journal.pmed.1001362. 578 
13.  Benetoli A, Chen TF, Schaefer M, Chaar B, Aslani P. Do pharmacists use social media 579 
for patient care? Int J Clin Pharm. 2017;39:364-372. doi:10.1007/s11096-017-0444-4. 580 
14.  Cain J, Romanelli F, Fox B. Pharmacy, social media, and health: Opportunity for 581 
impact. J Am Pharm Assoc. 2010;50:745-751. doi:10.1331/JAPhA.2010.09190. 582 
15.  Moorhead SA, Hazlett DE, Harrison L, Carroll JK, Irwin A, Hoving C. A new 583 
dimension of health care: systematic review of the uses, benefits, and limitations of 584 
social media for health communication. J Med Internet Res. 2013;15:e85. 585 
doi:10.2196/jmir.1933. 586 
16.  Burke-Garcia A, Scally G. Trending now: future directions in digital media for the 587 
public health sector. J Public Health (Oxf). 2014;36:527-534. 588 
doi:10.1093/pubmed/fdt125. 589 
17.  Shcherbakova N, Shepherd M. Community pharmacists, Internet and social media: An 590 
empirical investigation. Res Soc Adm Pharm. 2014;10:75-85. 591 
doi:10.1016/j.sapharm.2013.11.007. 592 
18.  Freeman B, Chapman S. Gone viral? Heard the buzz? A guide for public health 593 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
25 
 
practitioners and researchers on how Web 2.0 can subvert advertising restrictions and 594 
spread health information. J Epidemiol Community Health. 2008;62:778-782. 595 
doi:10.1136/jech.2008.073759. 596 
19.  Kayyali R, Hesson I, Mahdi A, Hamzat O, Adu A. Telehealth: Misconceptions and 597 
Experiences of Healthcare Professionals in England. Int J Pharm Pract. 2017; 25:203-598 
209. doi: 10.1111/ijpp.12340. 599 
20.  Aungst TD, Clauson KA, Misra S, Lewis TL, Husain I. How to identify, assess and 600 
utilise mobile medical applications in clinical practice. Int J Clin Pract. 2014;68:155-601 
162. doi:10.1111/ijcp.12375. 602 
21.  Mosa ASM, Yoo I, Sheets L. A systematic review of healthcare applications for 603 
smartphones. BMC Med Inform Decis Mak. 2012;12:67. doi:10.1186/1472-6947-12-604 
67. 605 
22.  Kayyali R, Peletidi A, Ismail M, Hashim Z, Bandeira P, Bonnah J. Awareness and Use 606 
of mHealth Apps: A Study from England. Pharmacy. 2017;5:33. 607 
doi:10.3390/pharmacy5020033. 608 
23.  Ghafoor S, Kayyali R, Nabhani S, Sobnath D, Philip N. Evaluating patients’ 609 
acceptability of alternative means of support for oral chemotherapy counselling and 610 
side effect management using a smartphone application. Int J Pharm Pract. 611 
2013;21:27-28. 612 
24.  Direito A, Pfaeffli Dale L, Shields E, Dobson R, Whittaker R, Maddison R. Do 613 
physical activity and dietary smartphone applications incorporate evidence-based 614 
behaviour change techniques? BMC Public Health. 2014;14:646. doi:10.1186/1471-615 
2458-14-646. 616 
25.  Office of National Statistics. Internet access – households and individuals. 617 
https://www.ons.gov.uk/peoplepopulationandcommunity/householdcharacteristics/ho618 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
26 
 
meinternetandsocialmediausage/bulletins/internetaccesshouseholdsandindividuals/201619 
6 ; 2016 Accessed 15.07.2017.  620 
26.  Statista. Facebook: global daily active users 2017. 621 
https://www.statista.com/statistics/346167/facebook-global-dau/ ; 2017 Accessed 622 
14.10.2017.  623 
27.  Mawdsley A, Schafheutle EI. Using Facebook to support learning and exam 624 
preparation in a final-year undergraduate pharmacy clinical therapeutics module. Curr 625 
Pharm Teach Learn. 2015;7(6):869-875. doi:10.1016/j.cptl.2015.08.010. 626 
28. Benetoli A, Chen TF, Schaefer M, Chaar B, Aslani P. Pharmacists’ perceptions of 627 
professionalism on social networking sites. Res Soc Adm Pharm. 2016; 13:575-588. 628 
doi:10.1016/j.sapharm.2016.05.044. 629 
29.  Petrakaki D, Barber N, Waring J. The possibilities of technology in shaping healthcare 630 
professionals: (re/de-)professionalisation of pharmacists in England. Soc Sci Med. 631 
2012;75:429-437. doi:10.1016/j.socscimed.2012.03.033. 632 
30.  Alkhateeb FM, Clauson KA, Latif DA. Pharmacist use of social media. Int J Pharm 633 
Pract. 2011;19:140-142. doi:10.1111/j.2042-7174.2010.00087. 634 
31.  Denecke K, Bamidis P, Bond C, et al. Ethical Issues of Social Media Usage in 635 
Healthcare. IMIA Yearb Med Informatics. 2015;10:137-147. doi:10.15265/IY-2015-636 
001.  637 
32.  Jick TD. Mixing Qualitative and Quantitative Methods: Triangulation in Action. Adm 638 
Sci Q. 1979;24:602. doi:10.2307/2392366. 639 
33.  Hassali MA, Subish P, Shafie AA, Ibrahim M. Perceptions and Barriers towards 640 
Provision of Health Promotion Activities among Community Pharmacists in the State 641 
of Penang, Malaysia. J Clin Diagnostic Res 2009;3: 1562-1568. 642 
34.  Kelly G, Micallef R, Fleming G, Shamin A. The Community Pharmacy Workforce in 643 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
27 
 
London. Health Education England. 2015. 644 
35.  Raosoft. Sample Size Calculator by Raosoft, Inc. 645 
http://www.raosoft.com/samplesize.html ; 2004 Accessed 06.01,2016 646 
36.  Sitzia J, Wood N. Response rate in patient satisfaction research: An analysis of 210 647 
published studies. Int J Qual Heal Care. 1998;10:311-317. 648 
doi:10.1093/intqhc/10.4.311. 649 
37.  Guest G, Bunce A, Johnson L. How Many Interviews Are Enough? Field methods. 650 
2006;18:59-82. doi:10.1177/1525822X05279903. 651 
38.  Clarke V, Braun V. Thematic analysis. In: Encyclopedia of Critical Psychology. New 652 
York, NY: Springer New York; 2014:1947-1952. doi:10.1007/978-1-4614-5583-653 
7_311. 654 
39.  Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In: Bryman 655 
A, Burgess R, editors. Analysing qualitative data. London: Routledge; 1993. pp. 173–656 
194. 657 
40.  Albert S, Duffy J. Differences in risk aversion between young and older adults. 658 
Neurosci neuroeconomics. 2012;2:3-9. doi:10.2147/NAN.S27184. 659 
41.  Prensky M. Teaching digital natives : Partnering for real learning. Corwin Press. 1st ed, 660 
London: Sage Publications; 2010. 661 
42. Venkatesh V, Davis FD. A theoretical extension of the technology acceptance model: 662 
Four longitudinal field studies. Management Science. 2000;46(2):186-204 663 
43.  Bradford NK, Caffery LJ, Smith AC. Awareness, experiences and perceptions of 664 
telehealth in a rural Queensland community. BMC Health Serv Res. 2015;15:427. 665 
doi:10.1186/s12913-015-1094-7. 666 
 667 
 668 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
28 
 
Table 1: Demographics of respondents  669 
Survey data National statistics of community 
pharmacist workforce (%) 
 Count 
(n=) 
% England 
Gender (N=257)     
Male 149 58.0 Male 40.6 
Female 106 41.2 Female 59.4 
Not stated 2 0.8   
Age (N=257)     
Under 24 19 7.4 Under 35 54.1 
24-35 years  114 44.4 Over 35 45.9 
36-45 years 50 19.5   
46-55 years 36 14.0   
56-65 years 35 13.6   
66-75 years 3 1.2   
Ethnicity (N=255)     
White 49 19.2 White 61.3 
Mixed 12 4.7 Non-white 38.7 
Indian 93 36.5   
Pakistani 35 13.7   
Bangladeshi 11 4.3   
Other Asian 13 5.1   
Black Caribbean 6 2.4   
Black African 21 8.2   
Chinese 10 3.9   
Any other ethnicity 5 2.0   
Type of pharmacy (N=254)     
Independent/small 
multiple (2-10 
pharmacies) 
162 63.8 Independent/small 
multiples 
45.21 
Large multiple (more 
than 10 pharmacies) 
92 36.2 Large multiples 54.79 
Years qualified (N=256)     
1-2 years 58 22.7   
3-6 years  69 27.0   
7-10 years  34 13.3   
11-20 years 29 11.3   
21-30 years  32 12.5   
> 31 years 34 13.3   
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Table 2a: Pharmacist perceptions of the use of social media  
  
Disagree Somewhat disagree 
Neither agree 
nor disagree 
Somewhat 
agree Agree 
Social media has a potential to become an 
established channel for patient–pharmacist 
communication  
18 (7%) 27 (10.5%) 50 (19.5%) 109 (42.4%) 53 (20.6%) 
Social media can be effectively used by 
pharmacists to improve patient communication  11 (4.3%) 35 (13.6%) 58 (22.6%) 101 (39.3%) 52 (20.2%) 
Social media needs to be used more at my 
workplace in communicating with patients  23 (8.9%) 44 (17.1%) 85 (33.1%) 69 (26.8%) 36 (14%) 
Social media may enhance pharmacist/patient 
relationships  19 (7.4%) 29 (11.3%) 81 (31.5%) 80 (31.1%) 48 (18.7%) 
Social media may improve patients' quality of life 19 (7.4%) 27 (10.5%) 87 (33.9%) 80 (31.1%) 44 (17.1%) 
Social media should be integrated with pharmacy 
services 29 (11.3%) 34 (13.2%) 77 (30%) 77 (30%) 40 (15.6%) 
Social media changes the way patients and 
pharmacists interact  19 (7.4%) 19 (7.4%) 75 (29.2%) 87 (33.9%) 57 (22.2%) 
Social media takes too much time to communicate 
with patients  22 (8.6%) 47 (18.4%) 85 (33.2%) 63 (24.6%) 39 (15.2%) 
Social media may improve patients' knowledge  14 (5.5%) 22 (8.6%) 70 (27.3%) 97 (37.9%) 53 (20.7%) 
Social media may cause patients to challenge 
pharmacists' knowledge  14 (5.4%) 25 (9.7%) 65 (25.3%) 79 (30.7%) 74 (28.8%) 
Better guidelines should be provided to help 
guide the pharmacist on the use of social media  8 (3.1%) 12 (4.7%) 57 (22.2%) 78 (30.4%) 102 (39.7%) 
Adapted from the survey tool created by Shcherbakova N, Shepherd M. Community pharmacists, Internet and social media: An empirical 
investigation. Res Soc Adm Pharm. 2014;10:75-85. 
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Table 2b: Pharmacist perceptions of the use of mobile health apps  
  
Disagree Somewhat disagree 
Neither 
agree nor 
disagree 
Somewhat 
agree Agree 
Mobile health apps have the potential to become an 
established tool in pharmacy service delivery  13 (5.1%) 14 (5.4%) 67 (26.1%) 117 (45.5%) 46 (17.9%) 
Mobile health apps need to be used more at my 
workplace when delivering pharmacy services  12 (4.7%) 38 (14.8%) 90 (35.2%) 87 (34%) 29 (11.3%) 
Mobile health apps may improve patients' quality of 
life  7 (2.7%) 12 (4.7%) 89 (34.6%) 100 (38.9%) 49 (19.1%) 
Mobile health apps should be integrated within 
pharmacy services 15 (5.8%) 25 (9.7%) 91 (35.4%) 90 (35%) 36 (14%) 
Mobile health apps change the way patients and 
pharmacists interact  14 (5.4%) 23 (8.9%) 81 (31.5%) 100 (38.9%) 39 (15.2%) 
Mobile health apps may improve patients' knowledge 7 (2.7%) 20 (7.8%) 68 (26.5%) 101 (39.3%) 61 (23.7%) 
Mobile health apps may cause patients to challenge 
pharmacists' knowledge  13 (5.1%) 22 (8.6%) 74 (28.8%) 85 (33.1%) 63 (24.5%) 
Better guidelines should be provided to help guide the 
pharmacist on the use of mobile health apps  7 (2.7%) 7 (2.7%) 67 (26.1%) 73 (28.4%) 103 (40.1%) 
Adapted from the survey tool created by Shcherbakova N, Shepherd M. Community pharmacists, Internet and social media: An empirical 
investigation. Res Soc Adm Pharm. 2014;10:75-85. 
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Table 3: Significant differences in perspectives of pharmacists from different demographics 
on the use of social media and mobile health apps for health promotion  
  
% of respondents who 
somewhat agree or agree Statistical significance 
Social media has a potential to become 
an established channel for patient–
pharmacist communication 
under 35s - 71.5% 
χ
2
=11.068, p=0.026 
over 35s - 54% 
Social media may improve patients' 
quality of life 
under 35s - 57.1% 
χ
2
=11.409, p=0.022 
over 35s - 38.7% 
Social media changes the way patients 
and pharmacists interact 
under 35s - 65.4% 
χ
2
=16.978, p=0.002 
over 35s - 46% 
Social media may improve patients' 
knowledge 
under 35s - 65.9% 
χ
2
=10.927, p=0.027 
over 35s - 50.8% 
Mobile health apps have the potential 
to become an established tool in 
pharmacy service delivery 
under 35s - 71.4% 
χ
2
 =11.524, p=0.021 
over 35s - 54.8% 
Mobile health apps need to be used 
more at my workplace when delivering 
pharmacy services 
under 35s - 56.1% 
χ
2
=13.870, p=0.008 
over 35s - 33.9% 
Mobile health apps may improve 
patients' quality of life 
under 35s - 67.7% 
χ
2
=12.706, p=0.013 
over 35s - 47.6% 
Mobile health apps should be 
integrated within pharmacy services 
under 35s - 58.6% 
χ
2
=11.590, p=0.021 
over 35s - 38.7% 
Mobile health apps change the way 
patients and pharmacists interact 
under 35s - 61.6% 
χ
2
=17.622, p=0.001 
over 35s - 46% 
Mobile health apps may improve 
patients' knowledge 
under 35s - 76% 
χ
2
=25.490, p<0.001 
over 35s - 49.2% 
Mobile health apps may cause patients 
to challenge pharmacists' knowledge 
under 35s - 63.1% 
χ
2
=14.055, p=0.007 
over 35s - 51.6% 
χ
2tests were carried out on responses comparing age, gender and ethnicity. This table only 
shows those comparisons that were significantly different. As is shown in the table there were 
statistical differences based on age but not based on gender or ethnicity.  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
32 
 
Table 4: Demographics of interviewees  
Participant demographics Count (n=) 
Gender   
Male 11 
Female 9 
Age   
Under 24 1 
24-35 years  10 
36-45 years 3 
46-55 years 4 
56-65 years 2 
Ethnicity   
White 5 
Indian 7 
Pakistani 2 
Black African 3 
Chinese 2 
Any other ethnicity 1 
Type of pharmacy   
Independent/small multiple (2-10 pharmacies) 12 
Large multiple (more than 10 pharmacies) 8 
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Appendix 1: Pharmacist perceptions of the use of social media as a tool in health 
promotion 
 
 
 
The survey is divided into 4 sections: 
A The role of pharmacists in public health 
B The use of social media by pharmacists 
C The use of mobile health applications by pharmacists 
D Demographics 
 
 
A. The role of pharmacists in public health 
 
A1. Which of the following advanced and enhanced services do you offer in your 
pharmacy? (Please tick ALL options that apply) 
 
□ Alcohol screening/brief intervention □ Chlamydia screening 
□ Chlamydia treatment   □ Emergency hormonal contraception 
□ Medicine Use Review   □ Minor ailments service 
□ Needle and syringe programme □ New Medicine Service  
□ NHS health check   □ Seasonal influenza vaccination 
□ Stop smoking     □ Supervised administration   
□ Weight management    □ None (Go to question A9.) 
□ Other  
 
If ‘Other’, please state:  
 
 
A2. How do you decide which services are delivered in your pharmacy?  
(Please tick ALL options that apply) 
 
□ Dictated by head office   □ Dictated by local authority 
□ Based on research of health needs of local area (e.g. using PNA report)  
□ Personal choice    □ Dictated by patient preference 
□ Other 
 
If ‘Other’, please state:  
 
 
A3. How do customers become aware of the services you offer? 
(Please tick ALL options that apply) 
 
□ Informed by pharmacy staff   □ Adverts in local papers 
□ Information in pharmacy window  □ Information on pharmacy website 
□ Information on pharmacy    □ Information on pharmacy  
 social media page     mobile application  
□ Notice in GP surgery     □ Word-of-mouth 
□ Don’t know     □ Other  
 
If ‘Other’, please state:  
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A4. Please specify if you feel any of the following barriers are preventing you from 
delivering more services in your pharmacy. 
(Please tick ALL options that apply) 
 
□ Lack of time    □ Lack of remuneration   
□ Patients not interested  □ Patients not aware of services offered 
□ Lack of personal interest  □  Lack of support from management  
□ Lack of support from local GP □  Lack of support from pharmacy team 
□ Lack of support from Local Authority □ Unsuitable consultation room  
□ Other 
 
If ‘Other’, please state:  
 
 
 
A5. Thinking about the current public health initiatives you deliver, and using the 
scale provided, how effective are they generally at promoting health behaviour 
change? (0 = not effective at all; 10 = very effective) 
 
 
 
0 1 2 3 4 5 6 7 8 9 10 
 
 
 
A6. What do you think helps your patients to make a positive health behaviour 
change? (Please tick ALL options that apply) 
 
□ Being Accountable to a healthcare   □ Support from family/friends 
 professional  
□ Support from a group of similar people  □ A behaviour change tool  
□ An awareness of the health risks  □ Don’t know 
 associated with not changing behaviour □ Other 
 
If ‘Other’, please state:  
 
 
 
 
A7. How do you encourage or support health behaviour change in patients? 
(Please tick ALL options that apply) 
 
□ Explain the benefits of making   □ Set and record goals over a  
 health-enhancing changes    period of time 
□ Help plan changes in small steps  □ Help patients feel positive about 
 over a period of time     the change 
□ Ensure patients understand the   □ Encourage patient to share their 
consequences of making changes    goals with others 
 to their health     □ Other 
 
If ‘Other’, please state:  
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A8. What resources do you signpost customers to when encouraging them to 
make health behaviour changes? (Please tick ALL options that apply) 
 
□ Company produced literature  □ Charity produced literature 
 
Please specify: ______________________ Please specify: _______________________ 
 
□ Health website   □ Social media page 
 
Please specify: ______________________ Please specify: _______________________ 
 
□ Mobile health app   □ Other 
 
Please specify: ______________________ Please specify: _______________________ 
 
□ Not applicable 
 
A9. Have you delivered any public health campaigns in the last year? 
(Please tick ONE option) 
□ Yes      □ No (Go to question A13.) 
 
A10. For which of the following topics have you delivered public health 
 campaigns? (Please tick ALL options that apply) 
 
□ Smoking cessation    □ Alcohol awareness 
□ Weight management    □ Sexual health 
□ Diabetes awareness    □ Physical activity  
□ Seasonal healthcare    □ Other 
 
If ‘Other’, please state:  
 
 
A11. Where did you deliver your health campaign(s)?  
(Please tick ALL options that apply) 
 
□ Pharmacy     □ Shopping centre 
□ Local school     □ Community centre 
□ GP surgery     □ Online (Company website)  
□ Online (Social media page)   □ Other 
 
If ‘Other’, please state:  
 
 
A12. How did you follow up with those people who interacted with your 
 health campaign(s)? (Please tick all options that apply) 
 
□ Telephone call    □ Email correspondence 
□ Newsletter     □ Text message 
□ Face-to-face consultation   □ Information leaflet 
□ Interaction on social media   □ Did not follow up 
□ Other 
 
If ‘Other’, please state:  
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Unless you have been directed to answer A13. please now go to section B 
 
A13. What has prevented you from delivering public health campaigns in the 
 last year? (Please tick ALL options that apply) 
 
□ Lack of time    □ Lack of remuneration   
□ Patients not interested  □  Lack of support from management  
□ Lack of personal interest  □  Lack of support from pharmacy team 
□ Lack of support from Local Authority □ Lack of support from local GP  
□ Other 
 
If ‘Other’, please state:  
 
 
B. The use of social media by pharmacists 
 
B1. Do you use social media? (Please tick ONE option) 
 
□ Yes      □ No (Go to question B12) 
 
B2. Which social media platform(s) do you have an account with?  
(Please tick ALL options that apply) 
 
□ Facebook  □ LinkedIn □ SnapChat □ Whatsapp 
□ Twitter   □ Instagram □ Google+ □ Pinterest 
□ YouTube  □ Slideshare □ Periscope □ Yik Yak 
□ Other 
 
If ‘Other’ please state:  
 
 
B3. How would you best describe your use of social media?  
(Please tick ONE option) 
 
□ Exclusively personal    □ Predominantly personal 
□ Equal personal and professional  □ Predominantly professional 
□ Exclusively professional   □ Not applicable 
 
B4. If you use social media for professional purposes, how do you use it? 
(Please tick ALL options that apply) 
 
□ To connect with other pharmacists □ To connect with other HCPs 
□ To connect with patients  □ To stay up-to-date with health literature 
□ For CPD    □ Not applicable 
□ Other 
 
If ‘Other’ please state:  
 
 
B5. Do you have different social media accounts for professional and personal 
use? (Please tick ONE option) 
 
□ Yes      □ No 
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B6. Is your professional social media account anonymised or is your real name 
visible? (Please tick ONE option) 
 
□ Anonymised     □ Not anonymised 
 
B7. If your account is anonymised, what is the reason for this? 
 
 
 
 
 
 
 
 
B8. Is the use of social media for personal or professional reasons allowed at your 
workplace? (Please tick ONE option) 
 
□ Yes      □ No (Continue to B9.) 
 
If ‘Yes’, do you use it to promote public health issues?  
 
If used for public health issues, which topics are promoted? 
 
 
B9. How frequently do you find yourself active on social media platforms for 
personal and professional use? (Please tick ONE option) 
 
□ Several times a day  □ Once a day  □ Few times weekly 
□ Once a week   □ Few times a month □ Once a month 
□ Less than once monthly 
 
B10. Do you recommend any social media pages to patients for health 
advice? (Please tick ONE option) 
 
□ Yes (Please specify then continue to B12.)  □ No (Continue to B11.) 
 
If yes, please specify which: 
 
 
B11. If you haven’t previously recommended any social media pages to 
 patients for health advice, what was the reason for this?  
(Please tick ALL options that apply) 
 
□ Not aware of any health social media pages  □ Don’t trust social media 
□ Don’t feel confident using social media myself □ Never thought to suggest 
□ Other 
 
If ‘Other’ please state:  
 
 
B12. Do customers ever ask to discuss health information they have found 
 on social media? (Please tick ONE option) 
 
□ Yes       □ No (Please go to B13.) 
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If you answered yes to B12., was the information they found reliable?  
 
 
 
 
Which social media pages, if any, have customers referenced? 
 
 
 
 
B13. Please answer the following questions using the scale provided1: 
 
Disagree Somewhat disagree 
Neither 
agree nor 
disagree 
Somewhat 
agree Agree 
Social media has a potential to 
become an established channel 
for patient–pharmacist 
communication1 
○ ○ ○ ○ ○ 
Social media can be effectively 
used by pharmacists to improve 
patient communication1 
○ ○ ○ ○ ○ 
Social media needs to be used 
more at my workplace in 
communicating with patients1 
○ ○ ○ ○ ○ 
Social media may enhance 
pharmacist/patient relationships1 ○ ○ ○ ○ ○ 
Social media may improve 
patients' quality of life1 ○ ○ ○ ○ ○ 
Social media should be 
integrated with pharmacy 
services 
○ ○ ○ ○ ○ 
Social media changes the way 
patients and pharmacists 
interact1 
○ ○ ○ ○ ○ 
Social media takes too much time 
to communicate with patients1 ○ ○ ○ ○ ○ 
Social media may improve 
patients' knowledge1 ○ ○ ○ ○ ○ 
Social media may cause patients 
to challenge pharmacists' 
knowledge1 
○ ○ ○ ○ ○ 
Better guidelines should be 
provided to help guide the 
pharmacist on the use of social 
media 
○ ○ ○ ○ ○ 
1. Shcherbakova, N and Shepherd, M.; Community pharmacists, internet and social media: An empirical investigation, Research 
in Social and Administrative Pharmacy, 10 (2014) p. e75-e85.  
 
B14. If a social media page was created and maintained by healthcare 
 professionals, would you recommend this to customers for health 
 advice? (Please tick ONE option) 
□ Yes       □ No (Go to question B20) 
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B15. Which of the following health promotion topics do you think this page 
 would be beneficial for? (Please tick ALL options that apply) 
 
□ Smoking cessation    □ Physical activity 
□ Alcohol awareness    □ Cancer 
□ Sexual health     □ Diabetes 
□ Weight management    □ Antibiotic awareness 
□ Other 
 
If ‘Other’ please state:  
 
 
 
B16. Would you be willing to input public health advice onto a social media 
 page? (Please tick ONE option) 
 
□ Yes       □ No (Go to section C) 
 
 
B17. In which format would you prefer to input this advice onto a social 
media page? 
(Please tick ALL options that apply) 
 
□ Text     □ Video   □ Pictures 
□ Blog    □ Other 
 
If ‘Other’ please state:  
 
 
 
B18. Would you expect a form of remuneration for this additional service? 
  (Please tick ONE option) 
 
□ Yes       □ No 
 
If ‘Yes’, please estimate how much per information entry.  
 
 
 
 
B19. How often would you be happy to update your patients on health related 
 information? (Please tick ONE option) 
 
□ More than twice daily    □ 1-2 times per day 
□ 4-5 times a week    □ 1-2 times per week  
□ Less than once a week 
 
 
 
Unless you have been directed to answer B20. please now go to Section C 
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B20. Please specify why you would not recommend a social media page run 
by healthcare professionals. 
  (Please tick ALL options that apply) 
 
□ I do not understand how to use  □ Liability and accountability 
 social media       
□ I am concerned about patient   □ I do not perceive a benefit to  
 confidentiality       using social media 
□ I am concerned about the language    
 barrier         
□ Other         
         
If ‘Other’ please state:  
 
 
C. The use of mobile health applications (apps) by pharmacists 
 
C1. Do you have access to a smart phone or tablet device in your pharmacy?  
(Please tick ONE option) 
 
□ Yes      □ No  
 
C2. Do you recommend any mobile health apps to patients for health advice? (Please 
tick ONE option) 
 
□ Yes (Please specify which then continue to C4.) □ No (Continue to C3.) 
 
If yes, please specify which: 
 
 
C3. If you haven’t previously recommended any mobile health apps to patients, what 
is the reason for this? 
(Please tick ALL options that apply) 
 
□ Not aware of any mobile health apps   
□ Don’t trust mobile health apps 
□ Don’t feel confident using mobile health apps myself   
□ Never thought to suggest it 
□ Other 
 
If ‘Other’ please state:  
 
 
C4. Do customers ever ask to discuss health information they have found on a mobile 
health app? (Please tick ONE option) 
 
□ Yes      □ No (Continue to question C5) 
If you answered yes to C4., was the information they found reliable?  
 
 
Which mobile health applications, if any, have customers referenced? 
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C5. Please answer the following questions using the scale provided: 
 
 
Disagree Somewhat disagree 
Neither 
agree nor 
disagree 
Somewhat 
agree Agree 
Mobile health apps have the 
potential to become an 
established tool in pharmacy 
service delivery 
○ ○ ○ ○ ○ 
Mobile health apps need to be 
used more at my workplace when 
delivering pharmacy services 
○ ○ ○ ○ ○ 
Mobile health apps may improve 
patients' quality of life ○ ○ ○ ○ ○ 
Mobile health apps should be 
integrated within pharmacy 
services 
○ ○ ○ ○ ○ 
Mobile health apps change the 
way patients and pharmacists 
interact 
○ ○ ○ ○ ○ 
Mobile health apps may improve 
patients' knowledge  ○ ○ ○ ○ ○ 
Mobile health apps may cause 
patients to challenge 
pharmacists' knowledge 
○ ○ ○ ○ ○ 
Better guidelines should be 
provided to help guide the 
pharmacist on the use of mobile 
health apps  
○ ○ ○ ○ ○ 
 
 
 
 
C6. If a mobile health app existed that was created and maintained by healthcare 
professionals would you recommend this to your customers? 
 
□ Yes      □ No (Continue to question C8) 
 
 
 
 
C7. Which of the following health promotion topics do you think this app would be 
beneficial for? (Please tick ALL options that apply) 
 
□ Smoking cessation   □ Physical activity 
□ Alcohol awareness   □ Cancer 
□ Sexual health    □ Diabetes 
□ Weight management   □ Antibiotic awareness 
□ Other 
 
If ‘Other’ please state:  
 
 
Unless you have been directed to answer C8. please now go to section D 
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C8. Please specify why you would not recommend a mobile health app maintained by 
healthcare professionals. (Please tick ALL options that apply) 
□ I do not understand how to use  □ Liability and accountability 
 mobile health apps    □ I do not perceive a benefit to  
□ I am concerned about patient    using mobile health apps 
 confidentiality      □ Too many mobile health apps 
□ I am concerned about the language   available, not sure which to 
 barrier       recommend 
□ Other             
If ‘Other’ please state:  
 
D – Demographics 
 
D1. What is your gender? (Please tick ONE option) 
□     Male                □     Female        □     Not stated 
  
D2. Which age category are you in? (Please tick ONE option) 
□     Under 24 years         □     24-35 years       □     36-45 years    
□     46-55 years            □     56-65 years      □     66-75 years 
□     Over 75 years            □     Not stated 
  
D3. How would you describe your ethnicity? (Please tick ONE option) 
□     White   □     White Other       □     Mixed 
□     Indian         □     Pakistani         □     Bangladeshi    
□     Other Asian        □     Black Caribbean     □     Black African   
□     Black Other        □     Chinese           □     Any other ethnicity 
□     Not stated 
If ‘other’, please specify: 
 
D4. How long have you been qualified as a pharmacist? (Please tick ONE option) 
□   1-2 years   □   3-6 years  □  7-10 years   
□   11-20 years   □   21-30 years  □  >30 years 
 
D5. Which type of community pharmacy do you work in predominantly?  
(Please tick ONE option) 
□ Independent     □ Small multiple (2-10 pharmacies) 
□ Large multiple (greater than 10 pharmacies) □ Other 
 If ‘other’, please specify: 
 
D6. Please state the first part of the post code of the pharmacy you work in:  
 
_______________________________________________________________________ 
 
The researcher is conducting interviews following the results of these surveys; can you be 
contacted to take part in these?  
□ Yes (Please include contact details below)  □ No 
 
Email address: _____________________________________________________________ 
 
Telephone number: _________________________________________________________ 
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APPENDIX 2 – Interview Schedule  
Good morning/afternoon, my name is xxx, from … University. Thank you for agreeing to 
give your time for this interview as a follow up to your completion of the survey “Pharmacist 
perceptions of the use of social media as a tool in health promotion.” This interview should 
take no longer than 20 minutes.  
What do you think the role of the pharmacist in public health is?  
Service delivery, advice giving, sign posting 
Tell me about any public health initiatives/services you have been involved in or have 
offered in the last year.  
Public health campaigns, local initiatives, smoking cessation, weight loss 
How do you decide what public health services to offer?  
PNA reports, personal interest, asked for by public 
How do you make the public aware of the public health services you offer? 
Word of mouth, leaflet, email, social media 
What is the format of delivery of your public health services?  
Face-to-face, telephone, email  
What resources do you use when delivering a service? Where do you signpost patients 
for further advice?  
Leaflets, guidelines e.g. NICE, websites 
How do you evaluate the impact of the public health services you deliver?  
Surveys, focus groups, record health outcomes 
What other public health services do you think pharmacists can potentially make a 
significant contribution to? And why?  
Drug misuse, sexual health, physical health 
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What help or support do you think could be given to pharmacists to help them in their 
public health role more broadly? 
Training, more remuneration, better trained staff 
What barriers are preventing you from delivering more public health services?  
Lack of time, lack of support staff, lack of patient interest 
What communication methods do you use when interacting with patients?  
Face-to-face, telephone, email, text messaging, social media 
Do you use social media? If yes, which platforms do you use?  
Facebook, Twitter, Instagram, SnapChat, How often do you use social media? 
For what purpose do you normally use social media?  
Connecting with family and friends, connecting with colleagues, connecting with patients 
What are your views on the use of social media as a tool in health promotion? 
Positive, negatives, opportunities, barriers 
Have patients ever approached you to discuss health-related information they have 
viewed on social media? If yes, was the information they viewed evidence-based and 
accurate?  
Give an example of an interaction you have had with a patient 
Can you describe any time you have contacted or been contacted by a patient on social 
media?  
What was the nature of the communication? Was health advice given? Was the patient 
directed to other health social media pages? 
What barriers would prevent you from providing health advice to patients on social 
media?  
Liability concerns, lack of time, lack of social media awareness, lack of confidentiality 
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If a health promoting social media page was created and maintained by healthcare 
professionals would you signpost patients to this? If yes, for which health topics do you 
think this would be most useful? If not, why not?  
Can you give any examples of when you think a page like this would be particularly useful? 
What further training would you need in order to use social media as a tool in health 
promotion?  
How to use social media, how to maintain professional boundaries on social media, how to 
effectively communicate with patients on social media 
Would you have any further suggestions or comments regarding this topic that have not 
been covered in this interview? If so, what are they please? 
 
Thank you very much for taking the time to meet with me and answer these questions. 
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